4//SEC Filing
Smith Stan 4
Accession 0001127602-25-016869
CIK 0001878313other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 4:42 PM ET
Size
7.5 KB
Accession
0001127602-25-016869
Insider Transaction Report
Form 4
Smith Stan
Director
Transactions
- Purchase
Warrants
2025-06-03$1.71/sh+33,333$56,999→ 33,333 total(indirect: See Footnote)Exercise: $1.71From: 2025-12-03Exp: 2030-06-03→ Common Stock (33,333 underlying) - Purchase
Common Stock
2025-06-03$1.50/sh+33,333$50,000→ 1,305,059 total(indirect: See Footnote)
Footnotes (4)
- [F1]The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on June 3, 2025.
- [F2]These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.
- [F3]These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options under the Issuer's 2021 Equity Incentive Plan on June 3, 2025. The options are exercisable beginning on the six-month anniversary of the issuance date and expire 5-years after the initial issuance date.
- [F4]These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust dated 1993.
Documents
Issuer
MAIA Biotechnology, Inc.
CIK 0001878313
Entity typeother
Related Parties
1- filerCIK 0001913199
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 4:42 PM ET
- Size
- 7.5 KB